Skip to main content
. 2022 Dec 15;12:1062592. doi: 10.3389/fonc.2022.1062592

Figure 1.

Figure 1

The TDT combines population-based knowledge with patient-specific information such as medical imaging, tumor genomics, etc. It can utilize physiologically based pharmacokinetic (PBPK) modeling towards individual therapy planning. AI may assist in different steps including data extraction and inverse methods for personalization of TDTs. The TDT can be updated with new collected data.